pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
Ziihera · news · pharmadog
← back to Ziihera
News mentioning Ziihera
12
stories
17d
6 potential blockbusters that could pave China’s path to 2030 ambitions
biospace
28d
Roche bets up to $813M on Zymeworks’ lung cancer trispecific T cell engager
biospace
Oct 13, 26
Analysts eye RevMed’s pancreatic cancer launch, Merck’s data blitz for Q3 earnings
biospace
Sep 9, 26
Beyond China: Five other overseas destinations for biopharma dollars
biospace
Sep 2, 26
UK regulator halts sales of Tavneos; UniQure seeks approval for Huntington's gene therapy
endpoints
Aug 27, 26
Roche nabs expanded FDA approval for diagnostic tied to Jazz’s cancer drug
fiercebiotech
Aug 26, 26
Jazz scores front-line gastric cancer nod from FDA for ‘practice-changing’ Ziihera
biospace
Aug 25, 26
New Jazz cancer drug approval could drive blockbuster sales
biopharma dive
Aug 25, 26
FDA approves Jazz's Ziihera in frontline gastric cancer
endpoints
Aug 25, 26
Recon: FDA expands labels for J&J’s Imaavy, Jazz's Ziihera; Teva faces Turkish antitrust probe over patent moves
raps
May 8, 26
Biomarker-Directed Therapies Move the GI Oncology Paradigm Beyond a One-Size-Fits-All Approach: With Michael J. Pishvaian, MD, PhD
onclive
May 7, 26
Approaching First-Line Treatment in PD-L1 CPS <1 HER2-Positive GEA
onclive